Metraipolis › archive › dc_cd5ac5368539

Navigating Recurrence in Clear Cell Renal Cell Carcinoma after Adjuvant Immunotherapy — Europe PMC PMID:42422057

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42422057
DOI
10.15586/jkc.v13i3.450
License (as archived)
solo-consultazione
Archived
2026-10-18T11:46:32.941Z
SHA-256 of the archived text
f41bb7bdead2650113ebccc69a737ac391c564f320f8b4fe9548aeb4ef97026e
Stable URL of this page
https://metraipolis.com/documento/dc_cd5ac5368539

How to cite

Navigating Recurrence in Clear Cell Renal Cell Carcinoma after Adjuvant Immunotherapy — Europe PMC PMID:42422057 — Europe PMC (en), https://europepmc.org/article/MED/42422057 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd5ac5368539 (Metraipolis archive dc_cd5ac5368539, sha256 f41bb7bdead2650113ebccc69a737ac391c564f320f8b4fe9548aeb4ef97026e)
BibTeX
@misc{dccd5ac5368539,
  title = {Navigating Recurrence in Clear Cell Renal Cell Carcinoma after Adjuvant Immunotherapy — Europe PMC PMID:42422057},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42422057},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd5ac5368539; sha256 f41bb7bdead2650113ebccc69a737ac391c564f320f8b4fe9548aeb4ef97026e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42422057. Agents can read the archived copy with the MCP tool read_document.